Skip to content
Sjogren's Syndrome News logo
  • Sjogren's Syndrome News on Facebook
  • Sjogren's Syndrome News on X
  • About Sjögren's
    What is Sjögren’s syndrome?
    Symptoms
    Causes
    Diagnosis
  • News
  • Columns
    Archived Columns
    • Diary of a Sjogie — Rena Newman
  • Health insights
  • FAQs
  • Clinical trials
    What are clinical trials?
    Types of clinical trials
    How do clinical trials work?
    Traditional vs. remote vs. hybrid clinical trials
    FAQs about clinical trials
  • What can we help you find today?

    • Sjogren's Syndrome News on Facebook
    • Sjogren's Syndrome News on X

June 14, 2022 News by Patricia Inácio, PhD

Function of Regulatory T-cells Impaired in Women With Sjögren’s: Study

The function of immune regulatory T-cells (Tregs) — cells that play a key role in dampening the body’s immune response — is impaired in women with Sjögren’s syndrome, a study suggests. Moreover, blood levels of a protein called sIL-2R were elevated in those with more severe disease. According to…

May 31, 2022 News by Patricia Inácio, PhD

Blood Protein Levels May Help ID Hidden Lung Disease in Sjögren’s

Elevated levels in the blood of the protein Krebs von den Lungen-6 (KL-6) — an indicator of lung inflammation — may help identify interstitial lung disease (ILD) in people with primary Sjögren’s syndrome who may not show symptoms, a study suggests. “Serum KL-6 level can serve as a valuable…

September 9, 2020 News by Inês Martins, PhD

Tumor Markers in Blood May Help Diagnose Lung Disease in Sjögren’s Patients, Study Finds

The tumor protein CA153 may be a valuable blood biomarker for the early diagnosis and treatment of interstitial lung disease (ILD) in people with primary Sjögren’s syndrome (pSS), a recent study found. The study, “Increases in tumor markers are associated with primary Sjögren’s syndrome-associated interstitial…

Recent Posts

  • Upcoming US clinical trial will test CLN-978 as Sjögren’s treatment
  • Key trial of Sjögren’s treatment expected to launch this summer
  • Men with Sjögren’s may be at higher pulmonary hypertension risk
  • MicroRNA may be therapeutic target for Sjögren’s: Study
  • Salivary gland ultrasound may assess primary Sjögren’s activity
  • Connect, learn, thrive this Sjögren’s Awareness Month, advocates say
  • FDA grants fast track designation to nipocalimab for Sjögren’s disease
  • Sexual dysfunction affects nearly 80% of women with Sjögren’s
  • Younger age, self-reactive antibodies tied to Sjögren’s kidney involvement
  • 2 in 3 Sjögren’s patients experience sexual challenges: Study


Envelope icon

Subscribe to our newsletter

Get regular updates to your inbox.

Bionews, Inc.

3 W Garden St
Suite 700
Pensacola, FL 32502
Website: bionews.com
Email: info@bionews.com
Phone: 1-800-936-1363

  • About Us
  • Leadership
  • Our Culture
  • Editorial Policy
  • Advertising Policy
  • Corrections Policy
  • Terms of Service
  • Privacy Policy
  • Careers
  • Contact Us
Disclaimer

This site is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

  • Sjogren's Syndrome News on Facebook
  • Sjogren's Syndrome News on X
Copyright © 2013-2025 All rights reserved.